Fortrea Holdings Inc. (FTRE) stock
FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3067% above fair value
$20.50+0.91 (+4.65%)
Close on Nov 18, 2026Market cap $1.98BP/E –Yield –
Fortrea operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Fortrea's operating cash flow for the twelve months ending Sep 30, 2026 was $201.80M, up 13353.3% year over year. For fiscal 2025 it was $113.50M, down 56.8% from the year before. The highest annual figure on record is $262.80M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $113.50M | -56.8% |
| FY2024 | Dec 31, 2024 | $262.80M | +56.1% |
| FY2023 | Dec 31, 2023 | $168.40M | +103.6% |
| FY2022 | Dec 31, 2022 | $82.70M | -51.3% |
| FY2021 | Dec 31, 2021 | $169.80M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $60.80M | -30.0% |
| Q2 FY2026 | Jun 30, 2026 | $28.90M | +32.6% |
| Q1 FY2026 | Mar 31, 2026 | -$17.00M | – |
| Q4 FY2025 | Dec 31, 2025 | $129.10M | +655.0% |
| Q3 FY2025 | Sep 30, 2025 | $86.80M | – |
| Q2 FY2025 | Jun 30, 2025 | $21.80M | -92.0% |
| Q1 FY2025 | Mar 31, 2025 | -$124.20M | – |
| Q4 FY2024 | Dec 31, 2024 | $17.10M | -7.1% |
| Q3 FY2024 | Sep 30, 2024 | -$2.40M | -226.3% |
| Q2 FY2024 | Jun 30, 2024 | $273.70M | +82.3% |
| Q1 FY2024 | Mar 31, 2024 | -$25.60M | – |
| Q4 FY2023 | Dec 31, 2023 | $18.40M | -21.7% |
| Q3 FY2023 | Sep 30, 2023 | $1.90M | -97.7% |
| Q2 FY2023 | Jun 30, 2023 | $150.10M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.00M | – |
| Q4 FY2022 | Dec 31, 2022 | $23.50M | – |
| Q3 FY2022 | Sep 30, 2022 | $80.90M | – |
See a number that looks wrong?